Anti-CA19-9 antibody [121SLE]
2
(1 Review)
|
(23 Publications )
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CA19-9 antibody [121SLE] (AB3982)
ab3982 staining CA19-9 in human colorectal adenocarcinoma by IHC-P (Formalin/Paraformaldehye fixed paraffin embedded tissue sections).
Reactivity data
Product details
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CA19-9 plays a role in cell-cell communication and adhesion contributing to the behavior of cancer cells regarding metastasis and invasion. It is part of a broader complex involving glycoproteins which is important in cell surface recognition and signaling events. In normal cellular roles functions are less prominent but the alterations in cancerous cells highlight its biological significance in oncogenesis.
Pathways
CA19-9 interacts with several signal transduction pathways that influence cellular processes like proliferation and migration. Notably it is involved in the EGF receptor pathway affecting cellular growth and survival mechanisms. It relates to glycosylation pathways which together with other proteins such as MUC1 modify cellular membranes in malignant tissues influencing tumor progression and evasion from immune detection.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Alternative Names
Publications (23)
Recent publications for all applications. Explore the full list and refine your search
Annals of surgery 280:e17-e25 PubMed38050737
2023
Applications
Unspecified application
Species
Unspecified reactive species
Glycobiology 33:637-650 PubMed37486674
2023
Applications
Unspecified application
Species
Unspecified reactive species
Discover. Oncology 14:20 PubMed36797531
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cancers 14: PubMed36551619
2022
Applications
Unspecified application
Species
Unspecified reactive species
World journal of surgical oncology 20:266 PubMed36008864
2022
Applications
Unspecified application
Species
Unspecified reactive species
Bioengineered 13:5525-5536 PubMed35166644
2022
Applications
Unspecified application
Species
Unspecified reactive species
Methods in molecular biology (Clifton, N.J.) 2460:33-44 PubMed34972929
2022
Applications
Unspecified application
Species
Unspecified reactive species
Clinics (Sao Paulo, Brazil) 76:e3318 PubMed34817046
2021
Applications
Unspecified application
Species
Unspecified reactive species
BioFactors (Oxford, England) 47:865-878 PubMed34339079
2021
Applications
Unspecified application
Species
Unspecified reactive species
Technology in cancer research & treatment 20:1533033821995282 PubMed33602046
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com